This paper is in the following e-collection/theme issue:

Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1481) Drug Repurposing and Off-Label Use (23) JMIR Theme Issue: COVID-19 Special Issue (2388) Viewpoints and Perspectives (483)

Published on in Vol 6, No 2 (2020): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19199, first published .
Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point

Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point

Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point

Authors of this article:

Moshe Rogosnitzky1 Author Orcid Image ;   Esther Berkowitz1 Author Orcid Image ;   Alejandro R Jadad2, 3 Author Orcid Image
Article Authors Cited by (32) Tweetations (394) Metrics

Moshe Rogosnitzky   1 ;   Esther Berkowitz   1 , MBChB, MA ;   Alejandro R Jadad   2, 3 , MD, DPhil, FRCPC, FCAHS, FRSA, LLD

1 MedInsight Research Institute, Rehovot, Israel

2 Program in Impactful Giving, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

3 Department of Anesthesiology and Pain Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada

Corresponding Author: